National NeuroDiagnostic Week. Thank you to each and every Technologist at JWM Neurology!
Author: judy
National Employee Appreciation Day 2022
Thank you to all of our JWM Staff Members for everything you do. We appreciate your dedication and hard work!
Celebrating National Women Physicians Day 2022
JWM Neurology Physicians Named As Top Doctors For 2021
Congratulations to all of the JWM Neurology physicians who were named by their peers as Indianapolis Monthly Magazine Top Doctors for 2021. Healthcare research and information company, Castle Connolly Medical, compiled this year’s Top Docs listing by asking physicians to recommend someone they would see themselves or recommend to a family member in Central Indiana.
National Nurse Practitioner Week 2021
Thank you to all of our JWM Neurology Nurse Practitioners!
JWM Neurology Recognizes Medical Assistant Week 2021
National Medical Assistants Recognition Week is October 18th through 22nd, 2021. Thank you to all of our JWM Neurology Medical Assistants!
National Physician Assistant Week 2021
Thank you to the JWM Neurology Physician Assistants!
JWM Neurology Supports Strike Out Stroke 2021
JWM Neurology is proud to support Strike Out Stroke at the Indianapolis Indians. Game night is September 1st and is dedicated to stroke awareness. While they last, tickets are “receive two-for-one” with the code “befast”.
Information About Philips Respironics Recall On Continuous & Non-Continuous Positive Airway Pressure Machines
Attention Positive Airway Pressure (PAP) Patients! Philips Respironics has issued a worldwide voluntary recall on its continuous and non-continuous Positive Airway Pressure Machines (PAP). What Should You Do?
FDA Approval of Aduhelm (aducanumab) For Alzheimer’s Disease
Regarding FDA-Approved Alzheimer’s Disease Drug Aduhelm (aducanumab): JWM Neurology anticipates prescribing and administering the drug Aduhelm (aducanumab) to appropriate patients within next the few months. Appropriate patients could potentially be individuals with a diagnosis of Mild Cognitive Impairment or mild stage dementia due to Alzheimer’s disease, who meet further criteria for safe administration of the… Continue reading FDA Approval of Aduhelm (aducanumab) For Alzheimer’s Disease
